Anna Falanga

Active 1985–2025

141
Papers
27,327
Citations
82
h-index
131
i10-index

Citations

Citations per year for Anna Falanga1987: 2 citations1988: 3 citations1989: 3 citations1990: 7 citations1991: 2 citations1992: 6 citations1993: 3 citations1994: 1 citations1995: 14 citations1996: 16 citations1997: 11 citations1998: 32 citations1999: 16 citations2000: 18 citations2001: 68 citations2002: 41 citations2003: 39 citations2004: 36 citations2005: 49 citations2006: 57 citations2007: 75 citations2008: 69 citations2009: 132 citations2010: 56 citations2011: 80 citations2012: 140 citations2013: 116 citations2014: 122 citations2015: 148 citations2016: 128 citations2017: 103 citations2018: 81 citations2019: 510 citations2020: 1,727 citations2021: 1,183 citations2022: 626 citations2023: 418 citations2024: 717 citations2025: 208 citations2026: 12 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,876 citing papers, 20.7% of this breakdownItaly: 893 citing papers, 9.8% of this breakdownUnited Kingdom: 650 citing papers, 7.2% of this breakdownCanada: 496 citing papers, 5.5% of this breakdownChina: 433 citing papers, 4.8% of this breakdownFrance: 432 citing papers, 4.7% of this breakdownSpain: 387 citing papers, 4.3% of this breakdownGermany: 354 citing papers, 3.9% of this breakdownNetherlands: 353 citing papers, 3.9% of this breakdownSwitzerland: 203 citing papers, 2.2% of this breakdownJapan: 198 citing papers, 2.2% of this breakdownAustria: 175 citing papers, 1.9% of this breakdown
0%20.7%Other 28.9%

Fields

  • Medicine87.5%
  • Biochemistry, Genetics and Molecular Biology6%
  • Immunology and Microbiology2.2%
  • Health Professions1.7%
  • Engineering0.6%
  • Computer Science0.5%
  • Other1.5%

Topics

  • Venous Thromboembolism Diagnosis and Management13.7%
  • COVID-19 Clinical Research Studies10.3%
  • Long-Term Effects of COVID-194.8%
  • Atrial Fibrillation Management and Outcomes3.2%
  • Blood Coagulation and Thrombosis Mechanisms3%
  • COVID-19 and healthcare impacts2.8%
  • Other62.2%

Coauthors

All papers

Open in search
  1. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

    Authors: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 1,475

  2. Cancer-associated venous thromboembolism

    Authors: , , , , , , , - Nature Reviews Disease Primers 2022 cited by 439

  3. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Viktoria Bitsadze, Dorit Blickstein, Mark Blostein, Isabel Bogalho, A.A.G.S. Brandāo, Rodrigo T. Calado, Alain Carpentier, José Ceresetto, Rufaro S Chitsike, J. Connault, Catarina Jacinto Correia, Benjamin Crichi, Erich Vinícius De Paula, Ahmet Muzaffer Demir, Laure Deville, Ludovic Doucet, Vera Dounaevskaia, C. Durant, Ellis Martin, Joseph Emmerich, Anna Falanga, Carme Font, Enrique Gallardo, Thomas Gary, Filipe Gonçalves, Jean‐Christophe Gris, Hiromi Hayashi, A. Hij, Luis Jara‐Palomares, David Jiménez, J. Kh. Khizroeva, Michel N'Guessan, Florian Länger, C. Le Hello, Christine Le Maignan, Ramón Lecumberri, Lai Heng Lee, Zachary Liederman, Luisa Lopes dos Santos, Duarte Machado, А. D. Makatsariya, Alberto Maneyro, Zora Marjanovic, Serban Milhaileanu, Manuel Monréal, Sara Moráis, António Moreira, Mikio Mukai, Arlette Ndour, Luciana Correa Oliveira de Oliveira, Remedios Otero-Candelara, Maria Carolina Tostes Pintão, Florian Posch, Pascal Prilollet, Hanadi Rafii, Daniel Dias Ribeiro, Hanno Riess, Marc Righini, Helia Robert‐Ebadi, Cynthia Rothschild, André Roussin, José Antonio Rueda Camino, Pedro Ruiz‐Artacho, Gleb Saharov, Joana Santos, M. Sebuhyan, Ali Shamseddine, Galia Spectre, Alì Taher, Javier Trujillo‐Santos and 6 more - The Lancet Oncology 2022 cited by 448

  4. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline

    Authors: , , , , , , , , , , , , , - Annals of Oncology 2023 cited by 384

  5. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 cited by 317

  6. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , - Blood 2018 cited by 798

  7. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John W. Eikelboom, Ido Weinberg, Sam Schulman, Marc Carrier, Gregory Piazza, Joshua A. Beckman, Philippe Gabríel Steg, Gregg W. Stone, Stephan Rosenkranz, Samuel Z. Goldhaber, Sahil A. Parikh, Manuel Monréal, Harlan M. Krumholz, Stavros Konstantinides, Jeffrey I. Weitz, Gregory Y.H. Lip - Journal of the American College of Cardiology 2020 cited by 2,939

  8. Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes

    Authors: , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2022 cited by 157

  9. Coagulation and cancer: biological and clinical aspects

    Authors: , , - Journal of Thrombosis and Haemostasis 2012 cited by 565

  10. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark Blostein, Isabel Bogalho, Barbara Bournet, Patricia Casais, Alain Carpentier, Gabriela Cesarman‐Maus, Joydeep Chakbrabartty, Hugo Clemente, J. Connault, Ludovic Doucet, C. Durant, Joseph Emmerich, Anna Falanga, Clemens Feistritzer, Carme Font, Charles W. Francis, Enrique Gallardo, Thomas Gary, Jean‐Christophe Gris, Cecilia Guillermo, A. Hij, Russel Hull, Takayuki Ikezoe, Luis Jara‐Palomares, Nigel S. Key, Jamilya Khrizroeva, Maral Koolian, Florian Länger, C. Le Hello, Ramón Lecumberri, Lai Heng Lee, Howard A. Liebman, Luisa Lopes Dos Santos, Duarte Machado, Isabelle Madelaine, А. D. Makatsariya, Mario Mandalà, Anthony Marayevas, Zora Marjanovic, Christine Marosi, Ellis Martin, Luis Meillón, E. Messas, António Moreira, Ahmet Muzaffer Demir, Arlette Ndour, Michel N'Guessan, Remedios Otero, Vanessa Pachón Olmos, Ana Pais, Florian Posch, Matthias Preusser, H. Riess, Marc Righini, Cynthia Rothschild, André Roussin, José Antonio Rueda-Camino, Pedro Ruiz‐Artacho, Sanjith Saseedharan, Ali Shamseddine, Gerald A. Soff, Hans Stricker, Vicky Tagalakis, Alì Taher, Toussaint Toutou, Javier Trujillo‐Santos, Stéphane Villiers, Raymond Wong, Norizaku Yamada - The Lancet Oncology 2019 cited by 658

  11. ISTH interim guidance on recognition and management of coagulopathy in COVID‐19

    Authors: , , , , , , , - Journal of Thrombosis and Haemostasis 2020 cited by 2,007

  12. Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexey Khotuntsov, Alisha Oropallo, Alison Slocombe, Allan Kelly, Amanda Clark, Amr Gad, Amy Arouni, Andor Schmidt, Andrea Berni, Andres Javier Kleiban, A Machowski, Andrey Kazakov, Ángel Gálvez, Ann Lockman, Anna Falanga, Anoop Chauhan, Antoni Riera‐Mestre, Antonino Mazzone, Armando D’Angelo, Artur Haddad Herdy, Atsushi Kato, Ayman Abd Elhamid Ebrahim Mahmoud Salem, Azlan Husin, Barbara Erdelyi, Barry Jacobson, Beatrice Amann‐Vesti, Bektaş Battaloǧlu, Benedicte Wilson, Benilde Cosmi, Bergmann Jean Francois, Berremeli Toufek, Beverley J. Hunt, Bhavesh Natha, Bisher Mustafa, Bonnie Chi Shan Kho, Boulon Carine, Brian Zidel, Brisot Dominique, Brousse Christophe, Bruno Trimarco, Canhua Luo, Carlos Alberto Cuneo, Carlos Jerjes Sanchez Diaz, Carsten Schwencke, Cas Cader, Celal Yavuz, Cesar Javier Zaidman, Charles A. Lunn, Chau‐Chung Wu, Cheng Hock Toh, Chern‐En Chiang, Chevrier Elisa, Chien‐Hsun Hsia, Chien-Lung Huang, Chi‐Hang Kevin Kwok, Chih-Cheng Wu, Chi‐Hung Huang, Chris Ward, Christian Opitz, Christina Jeanneret‐Gris, Chung Yin Ha, Chun‐Yao Huang, Claude Luyeye Bidi, Clifford Smith, Cornelia Brauer, Corrado Lodigiani, Françis Couturaud, Cynthia Wu, Daniel Staub, Daniel Theodoro and 375 more - Journal of Thrombosis and Thrombolysis 2020 cited by 115

  13. Mechanisms and risk factors of thrombosis in cancer

    Authors: , , , - Critical Reviews in Oncology/Hematology 2017 cited by 267

  14. EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer

    Authors: , , , , , , , , , , , , - HemaSphere 2022 cited by 98

  15. Myeloproliferative neoplasms and thrombosis

    Authors: , , - Blood 2013 cited by 407

  16. Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity

    Authors: , - Journal of Thrombosis and Haemostasis 2023 cited by 76

  17. ISTH guidelines for antithrombotic treatment in COVID‐19

    Authors: , , , , , , , , , , , , , , , , , - Journal of Thrombosis and Haemostasis 2022 cited by 179

  18. Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two‐year outcomes after the study closure

    Authors: , , , , , , , , , , , , , , , , , - Journal of Thrombosis and Haemostasis 2020 cited by 72

  19. Long‐term outcomes of patients with cerebral vein thrombosis: a multicenter study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paola Castellini, Stefano Barco, Marisa Barone, Maurizio Paciaroni, Andrea Alberti, Giancarlo Agnelli, Matteo Giorgi‐Pierfranceschi, Petr Ďulíček, Mauro Silingardi, Landini Federica, Angelo Ghirarduzzi, Eros Tiraferri, Vincenzo Di Lazzaro, Elena Rossi, Angela Ciminello, Samantha Pasca, Giovanni Barillari, Emanuele Rezoagli, Matteo Galli, Alessandro Squizzato, Alberto Tosetto - Journal of Thrombosis and Haemostasis 2012 cited by 161

  20. A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - JACC: Cardiovascular Interventions 2018 cited by 108

  21. Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients

    Authors: , , - Cancer treatment and research 2019 cited by 92

  22. Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance

    Authors: , , , , , , , , , , , , , , , - HemaSphere 2023 cited by 61

  23. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2015 cited by 1,373

  24. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Thrombosis and Haemostasis 2012 cited by 321